Paperpal Prime Logo

Drug Metabolism and Personalized Therapy : Impact Factor & More

eISSN: 2363-8915pISSN: 2363-8907

Key Metrics

CiteScore
2.9
H-Index
37
SJR
Q2Pharmacology (medical)
SNIP
0.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WALTER DE GRUYTER GMBH
Frequency Quarterly
General Details
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drug Metabolism and Personalized Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Metabolism and Personalized Therapy

Impact of TNF-alpha -308 G/A polymorphism on response to TNF inhibitors in Tunisian patients with inflammatory rheumatic diseases.
  • 24 Jul 2026
  • Drug metabolism and personalized therapy
MicroRNA sequencing reveals modulation of neurodegenerative miRNAs by Withania somnifera in human neuroblastoma SK-N-SH cells.
  • 20 Jul 2026
  • Drug metabolism and personalized therapy
The impact of antihistamine use on allergic reactions in pregnancy.
  • 17 Jul 2026
  • Drug metabolism and personalized therapy
Allergic reactions to anaesthetics in surgery: current challenges and perspectives.
  • 3 Jun 2026
  • Drug metabolism and personalized therapy
Superior seizure control with first-line levetiracetam in very low birth weight neonates: a 10-year comparative retrospective study.
  • 1 Jun 2026
  • Drug metabolism and personalized therapy
MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe.
  • 1 Jun 2026
  • Drug metabolism and personalized therapy
Impact of TNF-alpha -308 G/A polymorphism on response to TNF inhibitors in Tunisian patients with inflammatory rheumatic diseases.
  • 24 Jul 2026
  • Drug metabolism and personalized therapy
MicroRNA sequencing reveals modulation of neurodegenerative miRNAs by Withania somnifera in human neuroblastoma SK-N-SH cells.
  • 20 Jul 2026
  • Drug metabolism and personalized therapy
The impact of antihistamine use on allergic reactions in pregnancy.
  • 17 Jul 2026
  • Drug metabolism and personalized therapy
Allergic reactions to anaesthetics in surgery: current challenges and perspectives.
  • 3 Jun 2026
  • Drug metabolism and personalized therapy
Superior seizure control with first-line levetiracetam in very low birth weight neonates: a 10-year comparative retrospective study.
  • 1 Jun 2026
  • Drug metabolism and personalized therapy
MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe.
  • 1 Jun 2026
  • Drug metabolism and personalized therapy

FAQs on Drug Metabolism and Personalized Therapy